Fig. 1

a ChIP-Seq data analysis results for CEBPG of AML cell lines (K562 cell line included, tracks 1–6) and non-AML hematopoietic cells (tracks 7–10); b expression pattern of CEBPG between AML patients and healthy controls in public transcriptomic dataset (GSE114868); c CEBPG was highly expressed in hematologic tumors including AML according to the Cancer Cell Line Encyclopedia (CCLE; https://portals.broadinstitute.org/ccle); d western blotting results of the expression levels of CEBPG in AML/non-AML cell lines; e CEBPG markedly upregulated in AML cell lines compared with non-AML cell lines by western blotting